LMG Life Sciences Awards North America 2021: shortlist revealed

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

LMG Life Sciences Awards North America 2021: shortlist revealed

life-sciences-awards-2021-americas-for-dat.jpg

The LMG Life Sciences Awards is excited to present its shortlist for the 2021 North America Awards

The LMG Life Sciences Awards has released the full list of finalists for its 2021 North America awards.

The awards recognise the leading achievements and attorneys in life sciences law in the whole of the Americas.

Winners will be announced on September 22 2021.

A preview of the finalists can be found below, but the full list is available on the awards website.

The LMG Life Sciences research team carefully selected each finalist after a thorough research period which included an analysis of direct submissions, followed by interviews with law firms and in-house teams, client feedback, and much deliberation.

All of the work accepted for shortlisting closed during the research period, January 1 to December 31 2020.The awards do not recognise cases, deals, or transactions completed outside of this window.

If you have any questions regarding our research process, please contact our editor, Chris Adams: chris.adams@euromoneyny.com

The LMG Life Sciences Awards will be announcing the winners on September 22 at our awards ceremony.To find out more – and to find out how you can promote your success – please contact George Reeves: george.reeves@euromoneyny.com

 

Preview of the LMG Life Sciences Awards Americas 2021 shortlist:

Appellate Litigator of the Year – Intellectual Property

Deanne Maynard – Morrison & Foerster

Edward Reines – Weil Gotshal & Manges

Marky Perry – Gibson Dunn & Crutcher

Matthew Wolf – Arnold & Porter

Steffen Johnson – Wilson Sonsini Goodrich & Rosati

Hatch-Waxman Litigator of the Year – Branded

Adam Perlman – Latham & Watkins

Christopher Sipes – Covington & Burling

David Berl – Williams & Connolly

Jane Love – Gibson Dunn & Crutcher

Lisa Ferri – Mayer Brown

Lisa Pensabene – O’Melveny Myers

 

US Rising Star – Intellectual Property

Assad Rajani – Arnold & Porter

Heather Petruzzi – WilmerHale

Jennifer Nock – Rothwell Figg Ernst & Manbeck

Patrick Morris – Perkins Coie

Vanessa Yen – King & Spalding

 

Canadian Patent Litigator of the Year

Dominique Hussey – Bennett Jones

Harry Radomski – Goodmans

Kristin Wall – Norton Rose Fulbright

Peter Wilcox – Belmore Neidrauer

Sheldon Hamilton – Smart & Biggar

Steven Mason – McCarthy Tétrault

 

View the full 2021 shortlist.

more from across site and SHARED ros bottom lb

More from across our site

Licensing chief Patrik Hammarén also reveals that the company will rename its IPR business to better reflect its role in defining standards
The acquisition of Pecher & Partners follows the firm’s earlier expansion into litigation to create a ‘one-stop shop’
News of Via Licensing Alliance launching its first semiconductor patent pool and INTA electing a new president were also among the top talking points
Submit your nominations to this year's WIBL Americas Awards by January 23
The 2026 Life Sciences EMEA Awards is now open for entries. We are looking forward to reviewing and celebrating the industry's most impressive achievements and landmarks from the past year.
The tie-up between Perkins Coie and Ashurst may generate some striking numbers, but independent IP firms need not worry yet, according to practitioners
Perkins Coie’s US patent prosecution strength could provide Ashurst with an opportunity to enter an untapped market in Australia, but it may not be easy
Mitesh Patel at Reed Smith outlines why the US Copyright Office and courts have so far dismissed AI authorship and how inventors can protect AI-generated works
Xia Zheng, founder of AFD China, discusses balancing legal work with BD, new approaches to complex challenges, and the dangers of ‘over-optimism’
A dispute involving semiconductor technology and a partner's move from Hoffman Eitle to Hoyng Rokh Monegier were also among the top talking points
Gift this article